Identification of Mycobacterium tuberculosis CTL epitopes restricted by HLA-A*0201 in HHD mice

Iranian Biomedical Journal

Volumn 11, Issue 1, 2007, Pages 23-31

  Rafiei, Alireza ^a   Kiutade, Yiukito ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMAMATSU UNIVERSITY   (Japan)

Author keywords

DNA vaccine; Epitope; HHD mice; MPB51

Indexed keywords

GAMMA INTERFERON; HLA A ANTIGEN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENE SEQUENCE; IMMUNE RESPONSE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA, BACTERIAL; EPITOPES; FEMALE; HLA-A ANTIGENS; HUMANS; INTERFERON TYPE II; LYMPHOCYTE DEPLETION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; VACCINES, DNA;

MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 33847041054     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Pablos-Mendez, A.R.M., Laszlo, A., Binkin, N., Rieder, H.L., Bustreo, F., Cohn, D.L., Lambregts-Van Weezenbeek, C.S., Kim, S.J., Chaulet, P. and Nunn, P. (1998) Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl. J. Med. 338: 1641-1649.
2. Stenger, S.M.R. (1999) T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 2: 89-93
3. Kaufmann, S.H. (2000) Is the development of a new tuberculosis vaccine possible? Natl. Med. 6: 955-960.
4. Kaufmann, S.H. (1988) CD8+ T lymphocytes in intracellular microbial infections. Immunol. Today 9: 168-174.
5. Flynn, J.L., Goldstein, M.M., Triebold, K.J., Koller, B. and Bloom, B.R. (1992) Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U S A 89: 12013.
6. Sousa, A.O., Mazzaccaro, R.J., Russell, R.G., Lee, F.K., Turner, O.C., Hong, S., Van Kaer, L. and Bloom, B.R. (2000) Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 97: 4204-4208.
7. Kaufmann, S.H. (1993) Immunity to intracellular bacteria. Annu. Rev. Immunol. 11: 129-163.
8. Geluk, A., Taneja, V., Van Meijgaarden, K.E., Zanelli, E., Abou-Zeid, C., Thole, J.E., De Vries, R.R., David, C.S. and Ottenhoff, T.H. (1998) Identification of HLA class II-restricted determinants of Myco-bacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10797-10802.
9. Tascon, R.E., Colston, M.J., Ragno, S., Stavropoulos, E., Gregory, D. and Lowrie, D.B. (1996) Vaccination against tuberculosis by DNA injection. Natl. Med. 2: 888-892.
10. Cho, S, M. V., Thoma-Uszynski, S., Stenger, S., Serbina, N., Mazzaccaro, R.J., Flynn, J.L., Barnes, P.F., Southwood, S., Celis, E., Bloom, B.R., Modlin, R.L. and Sette, A. (2000) Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 97: 12210-122155.
11. Van Der Zee, R., Van Eden, W., Meloen, R.H., Noordzij, A. and Van Embden, J.D. (1989) Efficient mapping and characterization of a T cell epitope by the simultaneous synthesis of multiple peptides. Eur. J. Immunol. 19: 43-47.
12. Baldwin, S.L., D'Souza, C., Roberts, A.D., Kelly, B.P., Frank, A.A., Lui, M.A., Ulmer, J.B., Huygen, K., McMurray, D.M. and Orme, I.M. (1998) Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66: 2951-2959.
13. Orme, I.M. (1988) Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56: 3310-3312.
14. Ohara, N., Kitaura, H., Hotokezaka, H., Nishiyama, T., Wada, N., Matsumoto, S., Matsuo, T., Naito, M. and Yamada, T. (1995) Characterization of the gene encoding the MPB51, one of the major secreted protein antigens of Mycobacterium bovis BCG, and identification of the secreted protein closely related to the fibronectin binding 85 complex. Scand. J. Immunol. 41: 433-442.
15. Andersen, P. (1994) Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62: 2536-2544.
16. Ohara, N., Ohara-Wada, N., Kitaura, H., Nishiyama, T., Matsumoto, S. and Yamada, T. (1997) Analysis of the genes encoding the antigen 85 complex and MPT51 from Mycobacterium avium. Infect. Immun. 65: 3680-3685.
17. Abou-Zeid, C., Ratliff, T.L., Wiker, H.G., Harboe, M., Bennedsen, J. and Rook, G.A. (1988) Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect. Immun. 56: 3046-3051.
18. Huygen, K., Lozes, E., Gilles, B., Drowart, A., Palfliet, K., Jurion, F., Roland, I., Art, M., Dufaux, M., Nyabenda, J. (1994) Mapping of TH1 helper Tcell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect. Immun. 62: 363-370.
19. Munk, M.E., De Bruyn, J., Gras, H. and Kaufmann, S.H. (1994) The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T-cell responses. Infect. Immun. 62: 726-728.
20. Silver, R.F., Wallis, R.S. and Ellner, J.J. (1995) Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals. J. Immunol. 154: 4665-4674.
21. Huygen, K., Content, J., Denis, O., Montgomery, D.L., Yawman, A.M., Deck, R.R., DeWitt, C.M., Orme, I.M., Baldwin, S., D'Souza, C., Drowart, A., Lozes, E., Vandenbussche, P., Van Vooren, J.P., Liu, M.A. and Ulmer, J.B. (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2: 893-899.
22. Kamath, A.T., Feng, C.G., Macdonald, M., Briscoe, H. and Britton, W.J. (1999) Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun. 67: 1702-1707.
23. Geluk, A., Taneja, V., Van Meijgaarden, K.E., Zanelli, E., Abou-Zeid, C., Thole, J.E., De Vries, R.R., David, C.S. and Ottenhoff, T.H. (1998) Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10797-10802.
24. Pascolo, S., Bervas, N., Ure, J.M., Smith, A.G., Lemonnier, F.A. and Perarnau, B. (1997) HLA-A2.1-restricted education and cytolytic activity of CD8+ T lymphocytes from B2 microglobulin (2m) HLA-A2.1 monochain transgenic H-2Db B2m double knockout mice. J. Exp. Med. 185: 2043-2051.
25. Firat, H., Garcia-Pons, F., Tourdot, S., Pascolo, S., Scardino, A., Garcia, Z., Michel, M.L., Jack, R.W., Jung, G., Kosmatopoulos, K., Mateo, L., Suhrbier, A., Lemonnier, F.A. and Langlade-Demoyen, P. (1999) H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur. J. Immunol. 29: 3112-3121.
26. Parker, K.C., Bednarek, M.A. and Coligan, J.E. (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152: 163-175.
27. Rammensee, H., Bachmann, J., Emmerich, N.P., Bachor, O.A. and Stevanovic, S. (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
28. Uchijima, M., Yoshida, A., Nagata, T. and Koide, Y. (1998) Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J. Immunol. 161: 5594-5599.
29. Denis, O., Tanghe, A., Palfliet, K., Jurion, F., Van Den Berg, T.P., Vanonckelen, A., Ooms, J., Saman, E., Ulmer, J.B., Content, J. and Huygen, K. (1998) Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66: 1527-1533.
30. D'Souza, S., Rosseels, V., Romano, M., Tanghe, A., Denis, O., Jurion, F., Castiglione, N., Vanonckelen, A., Palfliet, K. and Huygen, K. (2003) Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect. Immun. 71: 483-493.
31. Vitiello, A., Marchesini, D., Furze, J., Sherman, L.A. and Chesnut, R.W. (1991) Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173: 1007-1015.
32. Lalvani, A., Brookes, R., Wilkinson, R.J., Malin, A.S., Pathan, A.A., Andersen, P., Dockrell, H., Pasvol, G. and Hill, A.V. (1998) Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 95: 270-275.
33. Mohagheghpour, N., Gammon, D., Kawamura, L.M., Van Vollenhoven, A., Benike, C.J. and Engleman, E.G. (1998) CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161: 2400-2406.
34. Beekman, N.J., Van Veelen, P.A., Van Hall, T., Neisig, A., Sijts, A., Camps, M., Kloetzel, P.M., Neefjes, J.J., Melief, C.J. and Ossendorp, F. (2000) Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J. Immunol. 164: 19898-19905.
35. Graff-Dubois, S., Faure, O., Gross, D.A., Alves, P., Scardino, A., Chouaib, S., Lemonnier, F.A. and Kosmatopoulos, K. (2002) Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broadspectrum tumor immunotherapy. J. Immunol. 169: 575-580.
36. Firat, H., Cochet, M., Rohrlich, P.S., Garcia-Pons, F., Darche, S., Danos, O., Lemonnier, F.A. and Langlade-Demoyen, P. (2002) Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wildtype/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int. Immunol. 14: 925-934.
37. Shirai, M., A.T., Nishioka, M., Nomura, T., Ikeda, K., Kawanishi, K., Engelhard, V.H., Feinstone, S.M. and Berzofsky, J.A. (1995) CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLAA2.1. J. Immunol. 154: 2733-2742.